Stuart J. Ings

859 citations

24 papers · 695 indexed · h-index 15

Co-authors: David C. Linch Michael Watts Kwee Yong Stephen Mackinnon Anthony H. Goldstone David Leverett N. Shaun B. Thomas Mike Watts
Topics: Hematopoietic Stem Cell Transplantation (18 papers)Immunotherapy and Immune Responses (5 papers)Mesenchymal stem cell research (4 papers)
Cited by: Hematology Genetics Transplantation
Journals: Blood British Journal of Cancer British Journal of Haematology
Partner nations: United Kingdom India China

In The Last Decade

Stuart J. Ings

24 papers receiving 681 citations

Peers

Countries citing papers authored by Stuart J. Ings

Since Specialization

Citations

This map shows the geographic impact of Stuart J. Ings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Ings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Ings more than expected).

Fields of papers citing papers by Stuart J. Ings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart J. Ings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Ings. The network helps show where Stuart J. Ings may publish in the future.

Co-authorship network of co-authors of Stuart J. Ings

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart J. Ings. A scholar is included among the top collaborators of Stuart J. Ings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart J. Ings. Stuart J. Ings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufacture 2022 ·Cytotherapy ·Maeve O’Reilly,(unknown),(unknown),Stuart J. Ings,(unknown),(unknown),Katarzyna Aleksandra Jalowiec,Lorna Neill,Karl S. Peggs,Claire Roddie	13
2	Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function 2019 ·Haematologica ·(unknown),Richard Szydlo,Mike Watts,Nishil Patel,(unknown),(unknown),Mark W. Lowdell,Stuart J. Ings,Chloe Anthias,J. Alejandro Madrigal,Stephen Mackinnon,Panagiotis Kottaridis,Ben Carpenter,Rachael Hough,Emma Morris,Kirsty Thomson,Karl S. Peggs,Ronjon Chakraverty	20
3	Post‐thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes 2016 ·British Journal of Haematology ·Daniel A. Morgenstern,Gulrukh Ahsan,(unknown),Stuart J. Ings,(unknown),Paul Veys,Penelope Brock,John Anderson,Persis Amrolia,Nicholas Goulden,Catherine M. Cale,Michael Watts	32
4	Re‐evaluation of progenitor thresholds and expectations for haematopoietic recovery based on an analysis of 810 autologous transplants: Implications for quality assurance 2016 ·British Journal of Haematology ·Michael Watts,Stuart J. Ings,(unknown),(unknown),(unknown),David C. Linch	8
5	Pre-determined small volume HPC-a harvests for cryopreservation using the continuous mononuclear cell (CMNC) procedure of the terumo optia apheresis machine 2015 ·Cytotherapy ·Michael Watts,(unknown),Stuart J. Ings,(unknown),(unknown),Richard J. Smith	2
6	High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma 2007 ·Biology of Blood and Marrow Transplantation ·Adrian Bloor,Kirsty Thomson,(unknown),Stephanie Verfuerth,Stuart J. Ings,Ronjon Chakraverty,David C. Linch,Anthony H. Goldstone,Karl S. Peggs,Stephen Mackinnon	75
7	Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony‐stimulating factor (G‐CSF): impact of age, sex, donor weight and type of G‐CSF used 2006 ·British Journal of Haematology ·Stuart J. Ings,(unknown),David Leverett,Stephen Mackinnon,David C. Linch,Michael Watts	115
8	Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects 2004 ·British Journal of Haematology ·Shirley D’Sa,Kwee Yong,Chara Kyriakou,(unknown),Karl S. Peggs,(unknown),Michael Watts,Stuart J. Ings,Kirit M. Ardeshna,Anthony H. Goldstone,Catherine Williams	12
9	Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model 2003 ·Blood ·Forhad Ahmed,Stuart J. Ings,Arnold Pizzey,Michael P. Blundell,Adrian J. Thrasher,(unknown),(unknown),David C. Linch,Kwee Yong	50
10	Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS^® (v2·1) and Isolex^® 300i (v2·5) clinical scale devices 2002 ·British Journal of Haematology ·Michael Watts,Tim C. P. Somervaille,Stuart J. Ings,Forhad Ahmed,Asim Khwaja,Kwee Yong,David C. Linch	34
11	The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. 2002 ·PubMed ·David Grimwade,Susan V. Outram,(unknown),Stuart J. Ings,Arnold Pizzey,Ricardo Morilla,Charles Craddock,David C. Linch,Ellen Solomon	26
12	A Clinically Applicable Method for the ex vivo Generation of Antigen–Presenting Cells from CD34+ Progenitors 2000 ·Vox Sanguinis ·Kirit M. Ardeshna,(unknown),Stuart J. Ings,Michael Watts,D C Linch,Stephen Devereux	8
13	ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m−2 and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients 2000 ·British Journal of Cancer ·Michael Watts,Stuart J. Ings,David Leverett,(unknown),Stephen Devereux,Anthony H. Goldstone,David C. Linch	46
14	Effect of Changes in Expression of the Amphotropic Retroviral Receptor PiT-2 on Transduction Efficiency and Viral Titer: Implications for Gene Therapy 2000 ·Human Gene Therapy ·Catherine Macdonald,Simon J. Walker,Michael Watts,Stuart J. Ings,David C. Linch,Stephen Devereux	16
15	Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile 2000 ·British Journal of Haematology ·Michael Watts,Stuart J. Ings,Michael Flynn,D. Dodds,Anthony H. Goldstone,David C. Linch	27
16	Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring 2000 ·Blood ·Karl S. Peggs,Stuart J. Ings,Panagiotis Kottaridis,Kwee Yong,Catherine Williams,Anthony H. Goldstone,Stephen Mackinnon	17
17	A Clinically Applicable Method for the ex vivo Generation of Antigen‐Presenting Cells from CD34+ Progenitors 2000 ·Vox Sanguinis ·Kirit M. Ardeshna,(unknown),Stuart J. Ings,M J Watts,D C Linch,Stephen Devereux	5
18	Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring 2000 ·Blood ·Karl S. Peggs,Stuart J. Ings,Panagiotis Kottaridis,Kwee Yong,Catherine Williams,Anthony H. Goldstone,Stephen Mackinnon	14
19	Cord blood progenitor cells have greater transendothelial migratory activity and increased responses to SDF‐1 and MIP‐3β compared with mobilized adult progenitor cells 1999 ·British Journal of Haematology ·Kwee Yong,(unknown),(unknown),(unknown),N. Shaun B. Thomas,Arnold Pizzey,Stuart J. Ings,Michael Watts,David C. Linch	30
20	Transmigration of CD34+ Cells Across Specialized and Nonspecialized Endothelium Requires Prior Activation by Growth Factors and Is Mediated by PECAM-1 (CD31) 1998 ·Blood ·Kwee Yong,Mike Watts,N. Shaun B. Thomas,Angela Sullivan,Stuart J. Ings,David C. Linch	99

About Stuart J. Ings

Stuart J. Ings is a scholar working on Hematology, Genetics and Transplantation, having authored 24 papers that have together received 695 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (18 papers), Immunotherapy and Immune Responses (5 papers) and Mesenchymal stem cell research (4 papers). The work is most often cited by research in Hematology (452 citations), Genetics (146 citations) and Transplantation (32 citations). Stuart J. Ings has collaborated with scholars based in United Kingdom, India and China. Frequent co-authors include David C. Linch, Michael Watts, Kwee Yong, Stephen Mackinnon, Anthony H. Goldstone, David Leverett, N. Shaun B. Thomas, Mike Watts, Angela Sullivan and Karl S. Peggs. Their work appears in journals such as Blood, British Journal of Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact